HEALTH

Perfecta Products expands distribution of Zim’s Maximum Heat

BY Michael Johnsen

NORTH LIMA, Ohio — Perfecta Products on Wednesday announced expansion of its Zim’s Maximum Heat external analgesic.

Maximum Heat is indicated for the temporary relief of muscle, back, shoulder and neck pain. It is the sister product of Perfecta’s Zim’s Max-Freeze. Zim’s Maximum Heat is formulated with aloe, arnica, vitamin E and tea tree oil.

Both the 2.5-oz. Zim’s Maximum Heat Roll-On and 3.5-oz. tube of Zim’s Maximum Heat retail for a suggested $10.49.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
HEALTH

ProPhase rejects second overture from Matrixx Initiatives

BY Michael Johnsen

DOYLESTOWN, Pa. — ProPhase Labs on Monday again rejected an acquisition proposal from Matrixx Initiatives. Matrixx’s latest offer was to acquire ProPhase for $1.60 per share in cash, up from a prior $1.40 per share proposal. 

"The extra 20 cents per share that Matrixx has tacked on to its prior inadequate offer does not alter our view that the current shareholders of ProPhase should benefit from the upside created by our current strategies, not the private equity owners of one of our primary competitors," stated Ted Karkus, ProPhase chairman and CEO. "Matrixx’s fundamental assertion that ProPhase supposedly ‘lacks the scale to effectively compete’ … is demonstrably false, as evidenced by the most recent 52-week industry retail sales data, which show that even without including ProPhase’s new products, our core Cold-Eeze Cold Remedy products continue to grow at double-digit rates while sales of many of our competitors’ products, including Matrixx’s Zicam-brand core cough-cold products, declined by double digits during the same time period."

Karkus added, "If we stay the course, we believe that our shareholders will be well rewarded for their patience."

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
HEALTH

Acura Pharmaceuticals introduces PSE product that will be less attractive to ‘meth cooks’

BY Michael Johnsen

PALATINE, Ill. — Acura Pharmaceuticals in December will launch an immediate-release pseudoephedrine tablet under the brand name Nexafed that will help impede conversion of the tablets into methamphetamine. Couched as the "next generation pseudoephedrine product," Nexafed is a 30-mg PSE hydrochloride tablet that utilizes Acura’s trademarked Impede technology. 

When using the "shake-and-bake" or "one-pot" method, the Impede technology yields approximately half as much methamphetamine as compared to a traditional PSE product — or 38% of the maximum possible pure methamphetamine out of each tablet — and consequently makes use of the cold medicine by "meth cooks" less profitable.

For other methods of baking meth out of PSE tablets, which require isolating the pseudoephedrine from the cold tablets, the Impede technology yields no usable pseudoephedrine. 

The brand is being positioned as the "higher road" option, where purchase of the brand is driven by reducing the appeal of PSE products sold at retail to criminals. "This is a high-recommendation category," noted Acura CEO Bob Jones. "When the pharmacist gets behind a product like Nexafed … that message will translate into product sales."

Eventually, Acura plans to file with the Drug Enforcement Agency for an exemption from the requirement that PSE products be sold behind the pharmacy counter. That would place a PSE product back on store shelves for the first time in seven years. Launching now will help Acura build a case of real-life positive outcomes, Jones told DSN. "We think that will [generate] the most impactful data that we can provide to regulators."

Impede Technology utilizes a proprietary mixture of inactive ingredients that forms a viscous, gelatinous mixture when dissolved in solvents typically used in the PSE extraction or methamphetamine production processes and trapping the PSE or converted methamphetamine to prevent its isolation or purification. The unique mixture of inactive ingredients in Nexafed is generally recognized as safe by the FDA.

Nexafed will be line-priced inline with other PSE tablet products.

keyboard_arrow_downCOMMENTS

Leave a Reply

M.BUDD says:
Dec-04-2012 05:09 pm

I didn't know about this product. I have heard about Zephrex-D from Highland Pharmaceuticals, using the Tarex formulation process which makes it quite impossible to be turned into methamphetamine: http://ephedrinewheretobuy.com/ephedrine-for-sale-over-the-counter-again Are these products similar? Is it the same formulation process? Same effectiveness for cold, allergy and asthma? Did Acura Pharmaceuticals get this exemption? In all cases I find it very promising: first it will hopefully reduce the number of meth labs and second it will force the industry to switch to this new generation meth-resistant products. Cheers, Mike

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?